Dosage: 4mg / 10mg
Specification: 20 tabs per box
Lenvatinib is approved by the US food and drug administration for the treatment of three types of cancer, with different dosages for different diseases. The daily dosages are as follows:
1. Liver cancer
The dose ofLenvatinib for liver cancer is closely related to the patient's weight. For patients with weight 60 kg, 12mg lovastinib daily;Weight > 60Kg, 8 mg daily Lenvatinib.
2. Renal cell carcinoma
A daily dose of 18mg of Lenvatinib is combined with 5mg of everolimus.
3. Differentiated thyroid cancer
Lenvatinib 24mg daily for the treatment of locally recurrent or metastatic, advanced, radioid-resistant, differentiated thyroid cancer.
We provide customers with quality products and services.
If you would like to leave us a comment please go to contact us